CytoDyn’s leronlimab reduces mortality by 82% at 14 days in critically ill COVID-19 patients
March 30 2021 - 7:08AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Mar 2024 to Apr 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2023 to Apr 2024